After reviewing clinical data and speaking with dozens of women using GLP-1 medications, I believe the cyclical appetite variation is real but minor
Studies show lasting relief for chronic conditions like knee pain
Type 2 diabetics have the following symptoms: They lose significant weight in just a short time They become more prone to infections They are unusually hungry or thirsty They urinate excessively They have high blood glucose levels (which is what hyperglycemia is) In the case of this ICD-10 code, the patient has hyperglycemia, meaning they have high blood glucose levels
These medications can reset the hunger-satiety balance that may have been disrupted by years of insulin resistance, emotional eating, or metabolic dysfunction. As a result, however, people on GLP-1s may unintentionally under-eat due to the lack of regular hunger cues, which can lead to muscle loss and nutrient deficiencies over time
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Early research suggests that microneedled patches and other novel delivery systems could theoretically work, but human efficacy and safety data remain limited